Adjunctive brexpiprazole in patients with major depressive disorder and anxiety symptoms: post hoc analyses of three placebo-controlled studies

OBJECTIVE: Episodes of major depressive disorder (MDD) characterized by high levels of anxiety symptoms are less likely to respond to some forms of antidepressant treatment (ADT). This report examines the effects of adjunctive brexpiprazole on depressive symptoms among patients with MDD and anxiety...

Descripción completa

Detalles Bibliográficos
Autores principales: Thase, Michael E, Weiller, Emmanuelle, Zhang, Peter, Weiss, Catherine, McIntyre, Roger S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6305164/
https://www.ncbi.nlm.nih.gov/pubmed/30587996
http://dx.doi.org/10.2147/NDT.S185815

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6305164/
https://www.ncbi.nlm.nih.gov/pubmed/30587996
http://dx.doi.org/10.2147/NDT.S185815

Ejemplares similares